Dr. Reddy’s Laboratories trades with traction on the bourses

22 Aug 2017 Evaluate

Dr. Reddys Laboratories is currently trading at Rs. 1953.95, up by 20.80 points or 1.08% from its previous closing of Rs. 1933.15 on the BSE.

The scrip opened at Rs. 1955.00 and has touched a high and low of Rs. 1963.00 and Rs. 1937.95 respectively. So far 16488 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 3394.95 on 28-Oct-2016 and a 52 week low of Rs. 1901.65 on 11-Aug-2017.

Last one week high and low of the scrip stood at Rs. 2031.30 and Rs. 1925.50 respectively. The current market cap of the company is Rs. 32285.29 crore.

The promoters holding in the company stood at 26.78%, while institutions and non-institutions held 43.38% and 13.68% respectively.

Dr. Reddy’s Laboratories through its wholly owned subsidiary Promius Pharma, LLC, has out-licensed the future development, manufacturing, and commercialization rights of DFD-06, a topical high potency steroid, to Encore Dermatology Inc. The drug is intended to be used for treatment of moderate to severe plaque psoriasis.

Under the terms of the agreement, Encore will be responsible for the commercialization of DFD-06 in the United States. Promius Pharma is eligible to receive certain pre- and post-commercialization milestone payments of up to $32.5 million, followed by fixed royalty payments on net sales.

Dr. Reddy’s Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.

Dr. Reddys Lab Share Price

1279.00 -1.40 (-0.11%)
16-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1782.80
Dr. Reddys Lab 1279.00
Cipla 1500.00
Zydus Lifesciences 913.90
Lupin 2089.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×